Mims Academy & Dm Academy
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Aster DM Healthcare Limited 26 August 2019 the Secretary Listing
26 August 2019 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051 Scrip Symbol: ASTERDM Dear Sir/Madam, Sub: Investor Presentation for Capital Market Day With reference to the captioned subject and the announcement made by the Company on August 8, 2019 relating to the Capital Market Day, which was scheduled for August 22, 2019, please find enclosed the Investor Presentation made. Kindly take the above said information on record as per the requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking You. Yours faithfully For Aster DM Healthcare Limited Puja Aggarwal Company Secretary and Compliance Officer Aster DM Healthcare Limited CIN- L85110KL2008PLC021703 IX/475L, Aster Medcity,Kuttisahib Road Near Kothad Bridge, South Chittoor PO Cheranalloor, Kochi- 682027, Kerala, India Tel: +91 484 6699999, Fax: +91 484 6699862 Email:[email protected] ASTER OM HEALTHCARE Investor and Analyst Meet – 22nd Aug 2019 www.asterdmhealthcare.com1 I I Disclaimer This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other conditions as in effect on the date hereof. Subsequent developments may impact the information contained in this presentation, which neither the Company nor its advisors or representatives are under an obligation to update, revise or affirm. -
Part 05.Indd
PART MISCELLANEOUS 5 TOPICS Awards and Honours Y NATIONAL AWARDS NATIONAL COMMUNAL Mohd. Hanif Khan Shastri and the HARMONY AWARDS 2009 Center for Human Rights and Social (announced in January 2010) Welfare, Rajasthan MOORTI DEVI AWARD Union law Minister Verrappa Moily KOYA NATIONAL JOURNALISM A G Noorani and NDTV Group AWARD 2009 Editor Barkha Dutt. LAL BAHADUR SHASTRI Sunil Mittal AWARD 2009 KALINGA PRIZE (UNESCO’S) Renowned scientist Yash Pal jointly with Prof Trinh Xuan Thuan of Vietnam RAJIV GANDHI NATIONAL GAIL (India) for the large scale QUALITY AWARD manufacturing industries category OLOF PLAME PRIZE 2009 Carsten Jensen NAYUDAMMA AWARD 2009 V. K. Saraswat MALCOLM ADISESHIAH Dr C.P. Chandrasekhar of Centre AWARD 2009 for Economic Studies and Planning, School of Social Sciences, Jawaharlal Nehru University, New Delhi. INDU SHARMA KATHA SAMMAN Mr Mohan Rana and Mr Bhagwan AWARD 2009 Dass Morwal PHALKE RATAN AWARD 2009 Actor Manoj Kumar SHANTI SWARUP BHATNAGAR Charusita Chakravarti – IIT Delhi, AWARDS 2008-2009 Santosh G. Honavar – L.V. Prasad Eye Institute; S.K. Satheesh –Indian Institute of Science; Amitabh Joshi and Bhaskar Shah – Biological Science; Giridhar Madras and Jayant Ramaswamy Harsita – Eengineering Science; R. Gopakumar and A. Dhar- Physical Science; Narayanswamy Jayraman – Chemical Science, and Verapally Suresh – Mathematical Science. NATIONAL MINORITY RIGHTS MM Tirmizi, advocate – Gujarat AWARD 2009 High Court 55th Filmfare Awards Best Actor (Male) Amitabh Bachchan–Paa; (Female) Vidya Balan–Paa Best Film 3 Idiots; Best Director Rajkumar Hirani–3 Idiots; Best Story Abhijat Joshi, Rajkumar Hirani–3 Idiots Best Actor in a Supporting Role (Male) Boman Irani–3 Idiots; (Female) Kalki Koechlin–Dev D Best Screenplay Rajkumar Hirani, Vidhu Vinod Chopra, Abhijat Joshi–3 Idiots; Best Choreography Bosco-Caesar–Chor Bazaari Love Aaj Kal Best Dialogue Rajkumar Hirani, Vidhu Vinod Chopra–3 idiots Best Cinematography Rajeev Rai–Dev D Life- time Achievement Award Shashi Kapoor–Khayyam R D Burman Music Award Amit Tivedi. -
Kozhikode Branch
INDIAN ACADEMY OF PAEDIATRICS - KOZHIKODE BRANCH IAP KOZHIKODE Activity of March -2019 IAP Kozhikode Office Bearers President - Secretary - Treasurer - Dr T P Ashraf Dr Nihaz Naha K Dr Vishnu Mohan P T Activity of March -2019 INDIAN ACADEMY OF PAEDIATRICS - KOZHIKODE BRANCH RARE DISEASE DAY OBSERVATION Date: 02-March-2019 On the occasion of rare disease day observation, IAP Kozhikode in association with Department Of Pediatrics, GMC Kozhikode and Lysosomal storage disease support society(LSDSS) conducted awareness program. The program was Inaugurated by Dr. VR Rajendran, Principal, GMC Kozhikode. Hrithunanda, a girl affected with Lysosomal Storage Disease lighted the Lamp. Dr C Sreekumar, Superintendent IMCH, Dr Mohandas Nair Addtl Superintendent, GMC Kozhikode, Dr Ashraf T P, President, IAP Kozhikode, Dr Ajithkumar V T, HOD Pediatrics, GMC Kozhikode, Dr Gireesh S, Addl. Professor, Pediatrics and Dr. Nisha, Pediatric Geneticist, Maulana Hospital, Perinthalmanna felicitated the function.Different aspects of LSD, long term management, challenges and state government initiatives in this field were discussed. Activity of March -2019 INDIAN ACADEMY OF PAEDIATRICS - KOZHIKODE BRANCH SIM WARS SIMULATION COMPETITION AT AIIMS, NEW DELHI Date: 03-March-2019 SIM WARS simulation competition at AIIMS, New Delhi on 3rd March A competition on pediatric intensive care scenarios simulated with a high fidelity *manikin* Sim Baby. 1st time such a competition conducted in India by PedStars & Inspire team. Attended by reputed institutions. Dr Manjusha.K,Senior Resident IMCH Kozhikode, Dr Nabeel Faisal.V, Dr Nikhil. K . Sunil and Dr Jasir Usman, mentored by Dr.Jayakrishnan. M. P, Additional Professor, Department of Pediatrics, GMC Kozhikode and and Dr. -
Aster DM Healthcare Limited June 23, 2020 the Secretary Listing
June 23, 2020 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 400051 Scrip Symbol: ASTERDM Dear Sir/Madam, Sub: Revised Investor Presentation for the quarter and year ended March 31, 2020 With reference to the captioned subject, please find enclosed the revised Investor Presentation on the Company’s performance for the quarter and year ended March 31, 2020. Due to technical distortion while converting the document to machine readable format the slides in the presentation are not appearing clearly. We request you to kindly take the above said information on record as per the requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Thanking You. Yours faithfully For Aster DM Healthcare Limited Puja Aggarwal Company Secretary and Compliance Officer Aster DM Healthcare Limited CIN- L85110KL2008PLC021703 IX/475L, Aster Medcity,Kuttisahib Road Near Kothad Bridge, South Chittoor PO Cheranalloor, Kochi- 682027, Kerala, India Tel: +91 484 6699999, Fax: +91 484 6699862 Email:[email protected] Investor Presentation – For the quarter ended 31st March 2020 1 Disclaimer ❑ This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other conditions as in effect on the date hereof. Subsequent developments may impact the information contained in this presentation, which neither the Company nor its advisors or representatives are under an obligation to update, revise or affirm. -
Cytopathology & Histopathology
Mahsheena KM, J Cytol Histol 2018, Volume 9 DOI: 10.4172/2157-7099-C1-014 4th International Conference on Cytopathology & Histopathology August 29-30, 2018 | Boston, USA The validity of immunocytochemistry in differentiating between benign and malignant thyroid neoplasms pre-operatively Mahsheena KM Aster MIMS hospital, India Preface: FNAC is the most commonly used diagnostic modality for the pre-operative assessment of thyroid neoplasms. However, FNAC, when used alone, has its own pitfalls including the inability to differentiate between benign and malignant follicular neoplasms, difficulty in identifying a follicular variant of papillary carcinoma etc. This study addresses the issue of whether preferential overexpression of galectin-3 in thyroid malignancies can serve to make a presurgical diagnosis between benign and malignant thyroid neoplasms on FNAC. The other marker used was TTF-1, to identify the thyroid origin of the neoplastic cells. Objective: To estimate the sensitivity, specificity and predictive values of galectin-3 and TTF-1 in detecting malignant neoplasms of the thyroid on FNA smears. Study Sample: FNA smears of solitary thyroid nodules taken at the Cytopathology division in the Department of Pathology, Aster MIMS hospital Calicut a tertiary health care system were analyzed from June 2016 to July 2017. Study Method: Immunocytochemistry was performed with galectin-3 and TTF-1 on fresh FNA smears by the standard protocol. Positive staining for galectin-3 was considered when any single epithelial cell showed cytoplasmic or nucleo- cytoplasmic immunostaining. Positive staining for TTF-1 was considered when any single epithelial cell showed nuclear immunostaining. Postoperative histological diagnosis represented the gold-standard. Results: Out of the total 39 cases Gal-3 positivity was seen in 100% (16/16) cases of malignancy and 9% (2/22) cases of benign thyroid lesions. -
Pravasi Bharatiya Divas 2013
Pravasi Bharatiya Divas 2013 Tag Line – Engaging Diaspora – The Indian Growth Story Sl. No. Sessions Topic Speakers 1. Plenary India’s Growth : Greater Shri Vayalar Ravi Minister of Overseas Indian India Session-I Opportunities Affairs 2. Dr. Montek Singh Deputy Chairman, Planning India Ahluwalia Commission 3. Shri Kamal Nath Minister of Urban India Development and Parliamentary Affairs 4. Shri Anand Sharma Minister of Commerce and India Industry 5. Shri P. K. Kunhalikutty Minister of Industries and India Information Technology 6. Shri K.M. Mani Minister of Finance, Law and India Housing, Government of Kerala 7. Ms. Naina Lal Kidwai President FICCI and Country India Head India, Director, HSBC Asia Pacific 8. Plenary Heritage and Diaspora Dr. Shashi Tharoor Minister of State for Human India Session-II Resource Development 9. Rt. Hon’ble Sir Anand Former Governor General, New Satyanand New Zealand Zealand 10. H.E. Dato Seri Dr S. Minister of Human Resource Malaysia Subramaniam 11. Hon’ble Jason Kenny, PC, Minister of Citizenship, Canada MP Immigration and Multiculturalism 12. Rt. Hon’ble Sandip Verma Parliamentary Under UK Secretary of State 13. Ms. Abike Dabiri Erewa Chairperson of the Nigerian Nigeria House of Representatives Committee 14. Shri Pavan K. Varma Author and former Bhutan Ambassador of India to Bhutan 15. Shri Gopinath Pillai Ambassador-at-Large, Singapore Singapore 16. Shri Ashook Ramsaran President, GOPIO International 17. Shri Yanktesh Permal Chairman, Reddy Group of Reddy Companies 18. Dr. Vidya Yeravdekar Director Symbiosis India International University, Pune 19. Shri Sant Singh Chatwal Chairman and CEO, Hampshire Hotels and Resorts 20. Plenary Engaging Young Overseas Shri Salman Khurshid Minister of External Affairs India 21. -
Unclaimed Dividend Warrant FY-2017
ISSUER_CODE FOLIO_NO PAYEE_NAME INSTR_AMOUNT INSTR_NUMBER FBL2017 2803 JOSEPH ABRAHAM K T 1080.00 14846 FBL2017 261 JOSEPH KAIMAPARAMBAN 3078.00 6054 FBL2017 IN30154951992913 SHIVANAND MALLAPPA PATIL 81.00 10000 FBL2017 1202000000265401 ANANT MUKUND SHAHANE 90.00 10003 FBL2017 1203600000269447 BHOSALE NAGANATH VASANT 62.10 10004 FBL2017 1201330001187341 SHIVAJI BANDAPPA KALGE 900.00 10005 FBL2017 1201060001020399 JEEVAN VANKATRAO SALUNKE 450.00 10006 FBL2017 1201330000652102 PRAFULLKUMAR DATTATRAY JAWALKAR 90.00 10009 FBL2017 1201330000894793 RAM PANDHARINATH BIRADAR 90.00 10010 FBL2017 IN30177415171549 AVINASH SUBHASH KARKOLE 45.00 10011 FBL2017 1203320007044938 PRADEEP RAMCHANDRARAO SHIVANE 180.00 10012 FBL2017 IN30220111367994 BHASKAR YADAVRAO SHINDE 72.90 10014 FBL2017 79140 VIDEOCON LEASING & INDUSTRIAL FIN LTD 1386.00 10015 FBL2017 IN30051318246739 PRAMOD RANGNATH SHEKATKAR 45.00 10018 FBL2017 IN30220111202304 DHUPPAD S G 3.60 10021 FBL2017 1203320000730720 HARISH MADHUKAR MARWADE 31.50 10026 FBL2017 1204470000507880 VISHAL TIRATHLAL ARORA 0.90 10028 FBL2017 1203600001419635 NILESH VIVEKRAO SHELKE 45.00 10029 FBL2017 IN30039412241219 MINAKSHI SURYAKANT SHAH 2025.00 1003 FBL2017 IN30023913836888 AVINASH P DETHE 37.80 10032 FBL2017 1204720010840449 VAIBHAV S RATNAPARKHI 13.50 10033 FBL2017 1201320000785284 DILIP KASHINATH SABALE 27.00 10038 FBL2017 IN30063610070491 SURESHKUMAR SHAH 2700.00 1004 FBL2017 1205600000013109 RAVINDRA SADASHIV JADHAV 45.00 10056 FBL2017 IN30051310890543 VIJAY DATTAJIRAO RANAWARE 22.50 10057 FBL2017 1203600000310275 -
JMSCR Vol||04||Issue||07||Page 11304-11309||July 2016
JMSCR Vol||04||Issue||07||Page 11304-11309||July 2016 www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v4i7.20 105 Cases of Macrocytosis- Etiologic Profile Reflecting Lifestyle Changes Authors Dr M.C.Savithri1, Dr K.P.Kavitha2 1Associate Professor, Dept of Pathology, Amala Institute of Medical Sciences, Thrissur, Kerala. India 2Senior Consultant, Dept of Pathology, Aster MIMS Hospital, Kozhikode, Kerala, India Introduction received in the Department of Pathology for Macrocytosis is encountered frequently during peripheral smear examination were selected for medical practice. Megaloblastic anemia (MA) due this study spanning a period of two years, from to Vitamin B12 or folate deficiency is the well April 2010 to end of March 2012. RBC indices known cause of macrocytosis. Pernicious anemia were obtained using using 5 part electronic is a major cause of megaloblastosis in Western hematology cell counters which were regularly world where their diet supplies the necessary calibrated and maintained. nutrients.[1] Nutritional megaloblastic anemia is Case histories, physical examination findings and very important in the Indian scenario.[2]However details of relevant investigations were retrieved non megaloblastic macrocytosis also forms an from Medical Records Section. There were 137 important group which includes alcoholic liver cases of macrocytosis. Those cases for which no disease, hemolytic anemias, leukemias etc. Kerala further details were available were excluded and is a an Indian State where literacy rate is high. The 105 cases selected. rural urban divide is much less pronounced here Retrospective studies have certain inherent and medical facilities are available even in the problems. -
NEWSLETTER August New.Cdr
Vol. 7 | July 2019 I N D I A N A C A D E M Y O F P E D I A T R I C S K E R A L A IAP MONTHLY E-BULLETIN OF IAP TKERALA DPRIVATE CIARCULATIOYN ONLY OFFICE BEARERS IAP KERALA Dr Santosh M K Dr Balachandar D Dr Narayanan M Dr Jayakumar PR President Secretary President Elect Vice President Dr Krishna Mohan R Dr Johny Sebasan Dr Riaz I Dr Vijayakumar M Treasurer Joint Secretary President's nominee Editor – Companion Dr Ranjith P Dr Vishnu Mohan P T Web Editor Editor - IAP today CENTRAL IAP PAST PRESIDENTS CENTRAL IAP Dr Remesh Kumar R Dr Abraham K Paul Dr MKC Nair Dr T U Sukumaran Honorary Secretary General EB Member President CIAP - 2004 President CIAP 2011 Dr S Sachidananda Kamath Dr PAM Kunju Dr Shimmy Paulose President CIAP 2015 EB Member EB Member President's Message We are really really happy to present July issue of IAP TODAY, monthly news leer of IAP Kerala, because this contains reports from all our 22 branches . Editors and all office bearers are doing excellent work. The acon plans PIVOT is in full swing. We have given maximum importance to Vamping dormant and semi dormant branches and we have succeeded fully in this venture. "Doctors day" was celebrated in great enthusiasm by all branches. 4th EB was in cochin, one of the most effecve EB. Immunisaon workshops conducted by almost all branches in kerala so also Central IAP Modules. We were in media almost everyday in july. -
STUDY on IMPACT of DREDGING on SHORELINE CHANGES Assessment of Impact on Shoreline Due to the Proposed Dredging Has Been Studied by IIT Chennai
STUDY ON IMPACT OF DREDGING ON SHORELINE CHANGES Assessment of impact on shoreline due to the proposed dredging has been studied by IIT Chennai. The study area is demarcated and is spatially georeferenced from the Google earth using spatially referenced points. The change in shoreline will be either erosion or accretion values along the coast. The erosion and accretion value is calculated using the shape area and with the corresponding shape length along the coast. The study indicates the shore line changes demarcated for 12 years and in the particular area namely Ernakulam the erosion rate is 1.38m/year which is maximum due to mouth opening. The erosion occurs in the other areas namely High court, Embarkation, Vypeen, Ponnarimangalam, Mulavukad hospital, Thevara yard, Kumbalam, Paliyamthuruthu and Kadamakuddy. There is no alarming erosion at any place. The maximum accretion rate is 32.91m in Fort Kochi for 12 years (2.74m/year). In the accretion areas namely Fort Kochi, Mattancherry, Bolgatty, Mulavukad Panchayat, Nettoor, Najrackal and Elakunnapuzha the coast is very much stable .The coast is stable in the no change areas such as Vytilla, Eroor, Kakkanad, Infopark, Mulavukad North, Korumkotta, Moolampilly, South chitoor, Thykoodam, Pizhala, Kothad, Chennur, Cheranalloor, Eloor, Varapuzha, Thundathumkadavu, Chariyamthuruth, Amritha hospital and Aster medicity. The accretion values are shown in Table-1 and it is represented in graph in the Figure-1. The maximum magnitude of erosion is 2.74m/yr and the coast is stable or accreting at most -
UAKON 2019 Scientific Programme
UAKON 2019 Scientific Programme 19.10.19 - HALL – A SESSION TIME PERIOD TOPIC SPEAKER CHAIR PERSONS 8.30 – 1 hour Video session 1 (5) 9.30 AM SAFE AND EFFICIENT MORCELLATION Dr Krishnamohan 1 TECHNIQUE DURING HOELP Ramaswami MIART, Kozhikode PERCUTANEOUS NEPHROLITHOTOMY USING Dr.Pankaj Bhirud, 2 SUPERPERC SHEATH - OUR INITIAL MIART, Kozhikode EXPERIENCE Dr Vijayan R ROBOTIC ASSISTED RENAL TRANSPLANT Dr Himanshu Sharma, Dr Venuchandran 1 3 SURGERY WITH RIGHT SIDED DONOR Aster Medcity, Kochi Dr Shanmugha Das KIDNEY ALLOGRAFT LAPAROSCOPIC NEPHRECTOMY IN Dr Vigneswara Srinivasan 4 EMPHYSEMATOUS PYELONEPHRITIS- S V, VPS lakeshore CHALLENGES hospital, Kochi ROBOT ASSISTED NEPHRO URETERECTOMY, Dr Sreerag KS, 5 BLADDER FIRST APPROACH WITHOUT JIPMER, Pondicherry REPOSITIONING OR REDOCKING 9.30 – 15 MIN UROLITHIASIS- EVALUATION AND Dr Suresh Bhat Dr Joju Akkara 9.45 AM MEDICAL MANAGEMENT Dr Satyendran 2 9.45 - 15 MIN URINARY DIVERSION Dr Ginil Kumar Nambiar 10 AM FOLLOWING RADICAL Dr Harris C H CYSTECTOMY- MY EXPERIENCE 10 - 60 MIN Best Podium session(6) 11 AM A SINGLE-CENTRE EXPERIENCE OF Dr Lal Darsan, 1 OUTCOMES OF LAPAROSCOPIC GMC, Kozhikode PYELOPLASTY PREVALENCE OF LOWER URINARY TRACT Dr Surajkumar Jajoo, 2 SYMPTOMS IN ADULTS ABOVE 50 YEARS OF GMC, Kottayam Dr Prasad AGE IN CENTRAL KERALA Cheeramattom FACTORS RESPONSIBLE FOR Dr Shubhendu Bhaduri, Dr Roy John 3 3 ORCHIDECTOMY IN TORSION TESTIS GMC, Kottayam Dr Baby Mathew Dr Sivaramakrishnan OUTCOMES OF ROBOTIC ASSISTED IVC Dr Sunil Bhat, P THROMBECTOMY (R-IVT) IN LEVEL I-III Aster medcity, -
About Aster DM Healthcare
FY2018 FY18 Revenue up by 13% Y-O-Y; EBITDA up by 79%; PAT up by 189% In FY18 operationalized two new hospitals in GCC • Medcare hospital – Sharjah, UAE (124 beds) • Aster Hospital – Doha, Qatar (61beds) Bangalore, May 21, 2018: Aster DM Healthcare, one of the largest private healthcare service providers in multiple GCC states and an emerging healthcare player in India, today announced its financial results for the quarter and full year ended March 31, 2018. Aster DM Healthcare is a 30-year-old integrated and comprehensive healthcare service organization with presence in 9 countries. The Company is one of the few entities across the globe providing the complete circle of care from primary, secondary, tertiary to quaternary medical care through its 19 hospitals, 101 clinics and over 200 pharmacies. These are manned by its17,335 employees from across the world, delivering on a simple yet strong promise to its people: “We’ll treat you well.” The Company has the unique distinction of serving people by providing quality healthcare to all segments of the society regardless of their economic or social positioning. In line with this, Dr. Azad Moopen, Founder Chairman and Managing Director at Aster DM Healthcare conceptualized the Company’s three brands - Medcare for the high income, Aster for the middle-income and Access for low- income strata of the population. The Company has an asset light business model wherein the land and civil structure of most of its hospitals are leased. It is also optimally positioned in the Medical tourism sector with a large number of GCC residents visiting India to avail quality and cost effective healthcare.